Nymox Pharmaceutical
NYMX
#10758
Rank
ยฃ13.95 M
Marketcap
Country
ยฃ0.15
Share price
0.00%
Change (1 day)
N/A
Change (1 year)

Earnings for Nymox Pharmaceutical (NYMX)

Earnings in 2023 (TTM): -ยฃ1.83 Million

According to Nymox Pharmaceutical's latest financial reports the company's current earnings are N/A. In 2022 the company made an earning of -ยฃ4.99 Million, an increase over its 2021 earnings that were of -ยฃ9.55 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Nymox Pharmaceutical from 1997 to 2023

Annual earnings

Year Earnings Change
2023 (TTM) -ยฃ1.83 Million-63.4%
2022 -ยฃ4.99 Million-47.71%
2021 -ยฃ9.55 Million6.61%
2020 -ยฃ8.95 Million-10.91%
2019 -ยฃ10.05 Million24.24%
2018 -ยฃ8.09 Million-20.03%
2017 -ยฃ10.11 Million2.71%
2016 -ยฃ9.85 Million-63.86%
2015 -ยฃ27.24 Million674.44%
2014 -ยฃ3.52 Million-6.11%
2013 -ยฃ3.75 Million-35.66%
2012 -ยฃ5.83 Million-20.76%
2011 -ยฃ7.35 Million38.33%
2010 -ยฃ5.32 Million35.59%
2009 -ยฃ3.92 Million11.8%
2008 -ยฃ3.51 Million-12.94%
2007 -ยฃ4.03 Million8.85%
2006 -ยฃ3.7 Million36.5%
2005 -ยฃ2.71 Million-4.4%
2004 -ยฃ2.84 Million-14.58%
2003 -ยฃ3.32 Million
2001 -ยฃ2.44 Million-20.54%
2000 -ยฃ3.07 Million21.72%
1999 -ยฃ2.52 Million-25.56%
1998 -ยฃ3.39 Million101.3%
1997 -ยฃ1.68 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
ยฃ14.31 B-866,411.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
ยฃ5.32 B-322,543.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
ยฃ5.51 B-334,112.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
ยฃ26.57 B-1,609,040.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
ยฃ1.14 B-69,142.11%๐Ÿ‡บ๐Ÿ‡ธ USA